Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: April 22, 2024
Introduction:
Although
post-COVID-19
syndrome
(PCS)
with
cognitive
impairment
is
increasingly
encountered
in
primary
care,
evidence-based
recommendations
for
its
appropriate
management
are
lacking.
Methods:
A
systematic
literature
search
evaluating
the
diagnosis
and
treatment
of
associated
PCS
was
conducted.
Practical
PCS-associated
care
summarized,
based
on
an
evaluation
pharmacological
plausibility
clinical
applications.
Results:
Currently,
pathology
remains
unclear
no
high-quality
data
to
support
targeted
interventions.
Existing
approaches
directed
towards
symptom
relief
where
counseling
chronicity
disease
regular
reassessments
at
4-
8-week
intervals
considered
reasonable.
Patients
should
be
informed
encouraged
adopt
a
healthy
lifestyle
that
centers
around
balanced
nutrition
physical
activities.
They
may
also
benefit
from
intake
vitamins,
micronutrients,
probiotics.
The
administration
Ginkgo
biloba
extract
could
offer
safe
potentially
beneficial
option.
Other
non-pharmacological
measures
include
physiotherapy,
digitally
supported
training,
and,
if
indicated,
ergotherapy
or
speech
therapy.
In
most
patients,
symptoms
improve
within
8
weeks.
If
serious,
ambiguous,
when
new
occur,
specialized
diagnostic
such
as
comprehensive
neurocognitive
testing
neuroimaging
initiated.
Very
few
patients
would
require
inpatient
rehabilitation.
Conclusion:
debilitating
condition
affect
daily
functioning
reduce
work
productivity.
Management
multidisciplinary
approach,
centering
physical,
cognitive,
therapies.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Feb. 29, 2024
Abstract
Post-COVID-19
syndrome
is
a
serious
complication
following
SARS-CoV-2
infection,
characterized
primarily
by
fatigue
and
cognitive
complaints.
Although
first
metabolic
structural
imaging
alterations
in
have
been
identified,
their
functional
consequences
remain
unknown.
Thus,
we
explored
the
impact
of
on
connectome
brain
providing
deeper
understanding
pathophysiological
mechanisms.
In
cross-sectional
observational
study,
resting-state
magnetic
resonance
data
66
patients
with
after
mild
infection
(mean
age
42.3
years,
57
female)
healthy
controls
42.1
38
mean
time
seven
months
acute
COVID-19
were
analysed
using
graph
theoretical
approach.
Network
features
quantified
measures
including
distance,
nodal
degree,
betweenness
Katz
centrality,
compared
between
both
groups.
Graph
correlated
clinical
quantifying
fatigue,
function,
affective
symptoms
sleep
disturbances.
Alterations
mainly
found
brainstem,
olfactory
cortex,
cingulate
thalamus
cerebellum
average
infection.
Additionally,
strong
correlations
severity,
functioning
daytime
sleepiness
from
scales
observed.
Our
study
confirms
relevance
changes
as
mediating
factors
for
persistent
improves
our
understanding.
Frontiers in Neurology,
Journal Year:
2024,
Volume and Issue:
15
Published: April 4, 2024
Corona
Virus
disease
2019
(COVID-19),
caused
by
the
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2),
has
presented
unprecedented
challenges
to
world.
Changes
after
COVID-19
have
had
a
significant
impact
on
patients
with
neurodegenerative
diseases.
This
study
aims
explore
mechanism
of
diseases
examining
main
pathways
central
nervous
system
infection
SARS-CoV-2.
Research
indicated
that
chronic
inflammation
and
abnormal
immune
response
are
primary
factors
leading
neuronal
damage
long-term
consequences
COVID-19.
In
some
patients,
concurrent
inflammatory
leads
increased
release
pro-inflammatory
cytokines,
which
may
significantly
prognosis.
Molecular
imaging
can
accurately
assess
severity
in
phase.
Furthermore,
use
FDG-PET
is
advocated
quantify
relationship
between
neuroinflammation
psychiatric
cognitive
symptoms
who
recovered
from
Future
development
should
focus
aggressive
post-infection
control
targeted
therapies
target
ACE2
receptors,
ERK1/2,
Ca
2+
.
Revista de Neurología,
Journal Year:
2025,
Volume and Issue:
79(12)
Published: Jan. 24, 2025
Introduction:
Long
COVID
is
defined
by
National
Institute
for
Health
and
Care
Excellence
(NICE)
as
the
set
of
signs
symptoms
that
develop
during
or
after
a
SARS-CoV-2
infection
continue
more
than
twelve
weeks
without
any
alternative
diagnosis.
One
most
frequent
persistent
reported
patients
verified
in
neuroimaging
studies
cognitive
dysfunction,
due
to
generalized
hypoconnectivity
diffuse
axonal
lesion
white
matter.
Therefore,
objectives
present
review
are
determine
how
long
functions
remain
affected
explore
which
beyond
three
months
follow-up
up
65
years
age
previous
neuropsychological
psychiatric
complications.
Methods:
A
systematic
was
performed
using
PRISMA
criteria
11
articles
were
included
through
comprehensive
search
five
different
databases:
PubMed,
Medline,
Scopus,
WOS
ProQuest.
The
risk
bias
assessed
Newcastle-Ottawa
scale.
Results:
Cognitive
problems
persist
over
time
improve
slowly,
although
seem
agree
areas
improved
significantly
one
year.
remained
impaired
longest
processing
speed
attention.
Conclusions:
These
alterations
cause
reduction
quality
life
work
capacity
manifest
need
intervention.
Frontiers in Psychology,
Journal Year:
2023,
Volume and Issue:
14
Published: Feb. 2, 2023
Background
and
purpose
The
coronavirus
disease
2019
(COVID-19)
has
been
associated
with
olfactory
dysfunction.
persistent
symptoms
of
anosmia
or
hyposmia
were
in
previous
studies
the
development
memory
impairment
mood
disturbances.
We
aimed
to
investigate
association
between
chronicity
reported
dysfunction
subjective
objective
cognitive
performance
long-COVID
patients
explore
whether
their
emotional
are
related
cognition.
Methods
One
hundred
twenty-eight
participants
recruited.
Reported
symptomatology,
complaints,
anxiety
depression
trait-anxiety
assessed.
Subjective
complaints
disturbances
compared
among
groups
as
an
acute
(AOD),
(POD),
nonexistent
(NOD)
symptom.
Seventy-six
volunteers
also
participated
a
face-to-face
session
assess
on
tests
general
function
verbal
declarative
memory.
Objective
AOD,
POD,
NOD
groups.
Results
similar
groups,
but
score
was
lower
than
those
no
at
any
time.
Participants’
positively
symptoms.
relationship
depressive
symptomatology
interacted
dysfunction,
it
only
occurred
without
Depressive
negatively
delayed
performance.
months
elapsed
from
diagnosis
assessment
predicted
Anxious
immediate
ability
recall
information
who
did
not
present
phase
infection.
Conclusion
Olfactory
infection
by
COVID-19
is
deficits
tests,
self-reported
These
findings
may
contribute
further
understanding
neuropsychological
aspects
long-COVID.
NeuroImage Clinical,
Journal Year:
2023,
Volume and Issue:
37, P. 103338 - 103338
Published: Jan. 1, 2023
COVID-19
neurological
manifestations
have
been
progressively
recognized.
Among
available
MRI
techniques,
diffusion
weighted
imaging
(DWI)
shows
promise
to
study
microstructure,
inflammation,
and
edema.
Previous
DWI
studies
reported
alterations
in
brain
diffusivity
patients,
as
assessed
by
morphologic
evaluation
of
scans
only.
The
aim
this
was
assess
quantify
patients
with
manifestations.
215
(olfactory
and/or
other
disorders)
36
normal
controls
were
compared
studied
T1-weighted
scans.
processed
a
semi-automatic
processing
procedure
specifically
developed
for
the
purpose
study,
Apparent
Diffusion
Coefficient
(ADC)
quantified
different
tissues
individual
white
matter
(WM)
gray
(GM)
regions.
Differences
ADC
values
between
controls,
well
patient
population
grouped
hospitalization
symptoms.
(median
[IQR]
=
52
[42
–
60]
years
age,
58
%
females),
91
hospitalized
26
needed
intensive
care.
84
had
hyposmia/ageusia
only,
while
131
ones
showed
disorders.
significantly
increased
WM
several
GM
regions
(p
<
0.001).
correlated
time
from
disease
onset
0.05).
Hospitalized
higher
alteration
than
non-hospitalized
all
tissues;
similarly,
disorders
those
olfactory
loss
highest
cognitive
or
memory
disorder
encephalitis
meningitis.
neither
associated
duration
nor
need
Current
findings
suggest
potential
non-invasive
marker
neuroinflammation
COVID-19,
transient
nature
same.
Future
longitudinal
are
confirm
our
findings.
Brain Communications,
Journal Year:
2023,
Volume and Issue:
5(4)
Published: Jan. 1, 2023
Alterations
of
the
limbic
system
may
be
present
in
chronic
phase
SARS-CoV-2
infection.
Our
aim
was
to
study
long-term
impact
this
disease
on
system-related
behaviour
and
its
associated
brain
functional
connectivity,
according
severity
respiratory
symptoms
acute
phase.
To
end,
we
investigated
multimodal
emotion
recognition
abilities
105
patients
from
Geneva
COVID-COG
Cohort
223
days
average
after
infection
(diagnosed
between
March
2020
May
2021),
dividing
them
into
three
groups
(severe,
moderate
or
mild)
symptom
We
used
multiple
regressions
partial
least
squares
correlation
analyses
investigate
relationships
recognition,
olfaction,
cognition,
neuropsychiatric
networks.
Six
9
months
following
infection,
exhibited
poorer
than
mild
for
expressions
fear
(P
=
0.03
corrected),
as
did
severe
disgust
0.04
corrected)
irritation
<
0.01
corrected).
In
whole
cohort,
these
performances
were
with
decreased
episodic
memory
anosmia,
but
not
depressive
symptoms,
anxiety
post-traumatic
stress
disorder.
Neuroimaging
revealed
a
positive
contribution
notably
cerebellum
default
mode,
somatosensory
motor
salience/ventral
attention
These
results
highlight
consequences
SARS-Cov-2
at
both
behavioural
neuroimaging
levels.
Viruses,
Journal Year:
2023,
Volume and Issue:
15(2), P. 533 - 533
Published: Feb. 14, 2023
The
COVID-19
outbreak
was
first
reported
in
2019,
causing
massive
morbidity
and
mortality.
majority
of
the
patients
survived
developed
Post-COVID-19
Syndrome
(PC19S)
varying
severity.
Currently,
diagnosis
PC19S
is
achieved
through
history
symptomatology
that
cannot
be
explained
by
an
alternative
diagnosis.
However,
heavy
reliance
on
subjective
reporting
prone
to
errors.
Besides,
there
no
unified
diagnostic
assessment
tool
classify
clinical
severity
patients.
This
leads
significant
difficulties
when
managing
terms
public
resource
utilization,
progression
monitorization
rehabilitation
plan
formulation.
narrative
review
aims
current
evidence
based
triple
assessment:
symptomatology,
biochemical
analysis
imaging
evidence.
Further
tools
can
monitor
patient’s
progression,
prognosis
intervals
monitoring.
It
also
highlights
high-risk
features
for
closer
earlier
Rehabilitation
programs
related
trials
are
evaluated;
however,
most
them
focus
cardiorespiratory
fitness
psychiatric
presentations
such
as
anxiety
depression.
research
required
establish
objective
comprehensive
facilitate
management
plans.
Brain Communications,
Journal Year:
2023,
Volume and Issue:
5(2)
Published: March 2, 2023
Fatigue
is
one
of
the
most
frequent
and
disabling
symptoms
post-COVID
syndrome.
In
this
study,
we
aimed
to
assess
effects
transcranial
direct
current
stimulation
on
fatigue
severity
in
a
group
patients
with
syndrome
chronic
fatigue.
We
conducted
double-blind,
parallel-group,
sham-controlled
study
evaluate
short-term
anodal
(2
mA,
20
min/day)
left
dorsolateral
prefrontal
cortex.
The
modified
impact
scale
score
was
used
as
primary
endpoint.
Secondary
endpoints
included
cognition
(Stroop
test),
depressive
(Beck
depression
inventory)
quality
life
(EuroQol-5D).
Patients
received
eight
sessions
were
evaluated
at
baseline,
immediately
after
last
session,
month
later.
Forty-seven
enrolled
(23
active
treatment
24
sham
group);
mean
age
45.66
±
9.49
years,
37
(78.72%)
women.
progression
time
since
acute
infection
20.68
6.34
months.
Active
associated
statistically
significant
improvement
physical
end
1
compared
stimulation.
No
effect
detected
for
cognitive
terms
secondary
outcomes,
an
treatment.
had
no
life.
All
adverse
events
reported
mild
transient,
differences
between
groups.
conclusion,
our
results
suggest
that
cortex
may
improve
Further
studies
are
needed
confirm
these
findings
optimize
protocols.
EBioMedicine,
Journal Year:
2023,
Volume and Issue:
94, P. 104711 - 104711
Published: July 13, 2023
Cognitive
deficits
are
among
the
main
disabling
symptoms
in
COVID-19
patients
and
post-COVID
syndrome
(PCS).
Within
brain
regions,
hippocampus,
a
key
region
for
cognition,
has
shown
vulnerability
to
SARS-CoV-2
infection.
Therefore,
vivo
detailed
evaluation
of
hippocampal
changes
PCS
patients,
validated
on
post-mortem
samples
at
acute
phase,
would
shed
light
into
relationship
between
cognition.Hippocampal
subfields
volume,
microstructure,
perfusion
were
evaluated
84
compared
33
controls.
Associations
with
blood
biomarkers,
including
glial
fibrillary
acidic
protein
(GFAP),
myelin
oligodendrocyte
glycoprotein
(MOG),
eotaxin-1
(CCL11)
neurofilament
chain
(NfL)
evaluated.
Besides,
biomarker
immunodetection
seven
necropsies
phase
contrasted
against
eight
controls.In
analyses
revealed
that
grey
matter
atrophy
is
accompanied
by
altered
microstructural
integrity,
hypoperfusion,
functional
connectivity
patients.
Hippocampal
structural
alterations
related
cognitive
dysfunction,
particularly
attention
memory.
GFAP,
MOG,
CCL11
NfL
biomarkers
PCS,
showed
associations
volume
changes,
selective
subfields.
Moreover,
post
mortem
histology
presence
increased
GFAP
reduced
MOG
concentrations
hippocampus
phase.The
current
results
evidenced
sequalae
present
cascade
pathological
indicating
axonal
damage,
astrocyte
alterations,
neuronal
injury,
already
from
phase.Nominative
Grant
FIBHCSC
2020
COVID-19.
Department
Health,
Community
Madrid.
Instituto
de
Salud
Carlos
III
through
project
INT20/00079,
co-funded
European
Regional
Development
Fund
"A
way
make
Europe"
(JAMG).
(ISCIII)
Sara
Borrell
postdoctoral
fellowship
No.
CD22/00043)
Union
(MDC).
predoctoral
contract
(FI20/000145)
(co-funded
Europe")
(MVS).
Fundación
para
el
Conocimiento
Madri+d
G63-HEALTHSTARPLUS-HSP4
(JAMG,
SOM).
EBioMedicine,
Journal Year:
2024,
Volume and Issue:
105, P. 105191 - 105191
Published: June 13, 2024
Coronavirus
disease
2019
(COVID-19)
frequently
leads
to
neurological
complications
after
recovery
from
acute
infection,
with
higher
prevalence
in
women.
However,
mechanisms
by
which
SARS-CoV-2
disrupts
brain
function
remain
unclear
and
treatment
strategies
are
lacking.
We
previously
demonstrated
neuroinflammation
the
olfactory
bulb
of
intranasally
infected
hamsters,
followed
alpha-synuclein
tau
accumulation
cortex,
thus
mirroring
pathogenesis
neurodegenerative
diseases
such
as
Parkinson's
or
Alzheimer's
disease.